Taysha Gene Therapies Inc (TSHA) is down Friday morning, with the stock declining -2.90% in pre-market trading to 3.01. TSHA's short-term technical score of 99 indicates that the stock has traded more bullishly over the last month than 99% of stocks on the market. In the Biotechnology industry, which ranks 95 out of 146 industries, TSHA ranks higher than 100% of stocks. Taysha Gene Therapies Inc has risen 44.19% over the past month, closing at $2.50 on February 23. During this period of time, the stock fell as low as $2.13 and as high as $3.55. TSHA has an average analyst recommendation of Strong Buy. The company has an average price target of $7.50.
TSHA has an Overall Score of 94. Find out what this means to you and get the rest of the rankings on TSHA!